مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

321
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

211
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

BRIGHT RENOPROTECTIVE PROPERTIES OF METFORMIN BEYOND BLOOD GLUCOSE REGULATORY EFFECTS BEYOND BLOOD GLUCOSE REGULATORY EFFECTS (REVIEW)

Pages

  423-428

Abstract

 Metformin, a biguanide drug, is widely prescribed to treat high blood glucose in individuals with type 2 diabetes mellitus. Type 2 diabetes mellitus is a troubling chronic disease and diabetic nephropathy is one of the most important complications of diabetes mellitus. Recent studies suggest that metformin, in addition to its efficacy in treating type 2 diabetes, may also have therapeutic efficacy in other conditions, including diabetic nephropathy or ameliorative property against tubular cell injury. Moreover, metformin significantly decreases albuminuria in patients with type 2 diabetes mellitus. However, the exact mechanisms beyond the effect of metformin on blood glucose are still unknown. Recent studies suggest that the therapeutic effect of metformin is mediated by its action on adenosine monophosphate-activated protein kinase in tissues. Various investigations show that metformin decreases intracellular reactive oxygen species. Metformin protects against tubular injury by restoring the biochemical alterations and regulation of oxidative stress on renal tubules. It also protects podocytes in nephropathy of diabetes. These findings can more strongly potentiate the clinical use of metformin in the prevention of nephropathy of diabetes. In this regard, to better understand the metformin nephroprotective properties, more experimental rat models and clinical studies are needed.

Multimedia

  • No record.

    • Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    NASRI, HAMID, BARADARAN, AZAR, ARDALAN, MOHAMMAD REZA, MARDANI, SAEED, MOMENI, ALI, & RAFIEIAN KOPAEI, MAHMOUD. (2013). BRIGHT RENOPROTECTIVE PROPERTIES OF METFORMIN BEYOND BLOOD GLUCOSE REGULATORY EFFECTS BEYOND BLOOD GLUCOSE REGULATORY EFFECTS (REVIEW). IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 7(6), 423-428. SID. https://sid.ir/paper/309418/en

    Vancouver: Copy

    NASRI HAMID, BARADARAN AZAR, ARDALAN MOHAMMAD REZA, MARDANI SAEED, MOMENI ALI, RAFIEIAN KOPAEI MAHMOUD. BRIGHT RENOPROTECTIVE PROPERTIES OF METFORMIN BEYOND BLOOD GLUCOSE REGULATORY EFFECTS BEYOND BLOOD GLUCOSE REGULATORY EFFECTS (REVIEW). IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2013;7(6):423-428. Available from: https://sid.ir/paper/309418/en

    IEEE: Copy

    HAMID NASRI, AZAR BARADARAN, MOHAMMAD REZA ARDALAN, SAEED MARDANI, ALI MOMENI, and MAHMOUD RAFIEIAN KOPAEI, “BRIGHT RENOPROTECTIVE PROPERTIES OF METFORMIN BEYOND BLOOD GLUCOSE REGULATORY EFFECTS BEYOND BLOOD GLUCOSE REGULATORY EFFECTS (REVIEW),” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 7, no. 6, pp. 423–428, 2013, [Online]. Available: https://sid.ir/paper/309418/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    email sharing button
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    sharethis sharing button